TaiMed Biologics Inc. (TPEX:4147)
Taiwan · Delayed Price · Currency is TWD 53.30
-0.10 (-0.19%)
Apr 17, 2026, 1:30 PM CST
TaiMed Biologics Market Cap
TaiMed Biologics has a market cap or net worth of 14.56 billion as of April 17, 2026. Its market cap has decreased by -44.34% in one year.
Market Cap
14.56B
Enterprise Value
13.29B
Revenue
611.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
53.30
Market Cap Chart
Since June 28, 2010, TaiMed Biologics's market cap has increased from 2.58B to 14.56B, an increase of 464.31%. That is a compound annual growth rate of 11.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 14.56B | -12.91% |
| Dec 31, 2025 | 16.72B | -28.81% |
| Dec 31, 2024 | 23.48B | 13.20% |
| Dec 29, 2023 | 20.75B | 16.27% |
| Dec 30, 2022 | 17.84B | 0.17% |
| Dec 30, 2021 | 17.81B | -16.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lumosa Therapeutics | 21.94B |
| Sunmax Biotechnology | 21.79B |
| AP Biosciences | 16.69B |
| Polaris Group | 16.17B |
| Medigen Vaccine Biologics | 15.78B |
| EirGenix | 15.31B |
| Ever Supreme Bio Technology | 12.26B |
| CHO Pharma | 11.56B |